Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

<< Previous

Bullboard Posts

Next >>

Post by askretkaon Aug 14, 2021 3:26pm

223 Views

Post# 33706432

Coronavirus infection cures mans cancer

https://slate.com/technology/2021/04/cancer-covid-remission-treatment-viruses.html ---------- This is interesting because the French researchers I posted awhile back were doing research on which viruses infected cancer cell best based on their outer coats. Coronavirus snd Reovirus we two of them. ----------------------- Cheers!!

<< Previous

Bullboard Posts

Next >>

Options trading in a volatile macro environment